Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.

Contributed by: Business Wire

Tags

Health

Other Health

Research

Pharmaceutical

Science

Biotechnology

Intercept Pharmaceuticals, Inc.

More Like This

Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences

Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Pending Acquisition of Intercept Pharmaceuticals, Inc.

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Tiziana Life Sciences Announces Purchase of Shares by Chairman

GENESIS Pharma Announces an Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize RIPRETINIB in 14 EU Markets in Central and Eastern Europe

PR Newswire associated0

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG